See Apellis Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Apellis Pharmaceuticals's post-money valuation and revenue. Apellis Pharmaceuticals Stock Price, Funding, Valuation, Revenue & Financial StatementsThe latest price target for Apellis Pharmaceuticals ( NASDAQ: APLS) was reported by Baird on Tuesday, February 6, 2024. The analyst firm set a price target for 81.00 expecting APLS to rise to ...Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price. Apellis Pharmaceuticals has a strong track record of developing innovative therapies for patients with unmet medical needs. Find out why APLS stock is a speculative buy.Apellis investors reaped the benefits of that approval this week, namely a stock surge that saw the company’s share price jump 19% this week, from $55.49 at the close of trading February 17 to ...The upgrade of Apellis Pharmaceuticals, Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in ... The stock's price-to-GF-Value ratio stands at 0.45, with a GuruFocus Value of $144.67, indicating that Apellis Pharmaceuticals Inc is currently categorized as a Possible Value Trap, Think Twice ...Get Apellis Pharmaceuticals Inc (APLS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAPLS, Apellis Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Apellis Pharmaceuticals Price Performance. Shares of APLS opened at $68.47 on Friday. The firm has a market cap of $8.11 billion, a PE ratio of -13.04 and a …Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Apellis Pharmaceuticals Inc share price live 68.16, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart ...Summary. Apellis Pharmaceuticals experienced a roller-coaster ride in 2023, with its stock price fluctuating due to various factors. The approval of pegcetacoplan, the underlying ingredient in ...See Apellis Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Apellis Pharmaceuticals's post-money valuation and revenue. Apellis Pharmaceuticals Stock Price, Funding, Valuation, Revenue & Financial StatementsFeb 16, 2024 · Price Target. Based on short-term price targets offered by 16 analysts, the average price target for Apellis Pharmaceuticals, Inc. comes to $77.19. The forecasts range from a low of $49.00 to a ... Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...APLS - Apellis Pharmaceuticals, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)Get Apellis Pharmaceuticals Inc (APLS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsNov 29, 2023 ... As of November 29, 2023, 4:00 PM, CST, Apellis Pharmaceuticals Inc's stock price was $50.30. Apellis Pharmaceuticals Inc is up 6.66% from its ...The PE Ratio as of February 2024 (TTM) for Apellis Pharmaceuticals, Inc. ( APLS) is -12.93. According to Apellis Pharmaceuticals, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -12.93. This represents a change of 4.51% compared to the average of -12.37 of the last 4 quarters.Insights from analysts' 12-month price targets are revealed, presenting an average target of $67.67, a high estimate of $93.00, and a low estimate of $42.00. Experiencing a 2.49% decline, the ...Apellis Pharmaceuticals Inc stock is currently priced at $67.85, with a 24-hour trading volume of 843.01K. It has seen a -1.35% decreased in the last 24 hours and a +6.35% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $68.36 pivot point. If it approaches the $67.52 support level, significant …With A 55% Price Drop For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) You'll Still Get What You Pay For Jul 19. New minor risk - Share price stability Jul 18. General Counsel notifies of intention to sell stock ... Apellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderFind the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.Apellis Pharmaceuticals Inc stock price live 64.04, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart below. You can find more details by …Jul 19, 2023 ... With A 55% Price Drop For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) You'll Still Get What You Pay For · How Is Apellis Pharmaceuticals' Revenue&nb...Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Trade prices are …The PE Ratio as of February 2024 (TTM) for Apellis Pharmaceuticals, Inc. ( APLS) is -12.93. According to Apellis Pharmaceuticals, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -12.93. This represents a change of 4.51% compared to the average of -12.37 of the last 4 quarters.You can buy and sell Apellis Pharmaceuticals (APLS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...Get the latest dividend data for Apellis Pharmaceuticals, Inc. (APLS), including dividend history, yield, key dates, growth and other metrics. ... APLS · IEX Real-Time Price · USD. Add to Watchlist 68.78 +1.20 (1.78%) At close: Feb 16, 2024, 4:00 PM. 68.80 +0.02 (0.03%) After-hours: Feb 16, 2024, 7:29 PM EST. ... Apellis Pharmaceuticals' stock slides 14% …Apellis Pharmaceuticals has a strong track record of developing innovative therapies for patients with unmet medical needs. Find out why APLS stock is a speculative buy.Apellis Pharmaceuticals Inc stock price live 64.04, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart below. You can find more details by …Apellis Pharmaceuticals Price Performance. Shares of APLS opened at $68.47 on Friday. The firm has a market cap of $8.11 billion, a PE ratio of -13.04 and a beta of 0.93. The firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06.The Apellis Pharmaceuticals, Inc. stock price is closed at $ 59.61 with a total market cap valuation of $ 7.06B (118.50M shares outstanding). The Apellis Pharmaceuticals, Inc. is trading on NASDAQ with the sign APLS. Apellis Pharmaceuticals, Inc. price is up -1.84% in the past 24 hours.Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application. WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …The current price Apellis Pharmaceuticals (APLS) is trading at is $67.80, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also Watch The cap price of the capped call transaction is initially $63.14 per share of Apellis common stock, representing a premium of 100% above the last reported sale price of $31.57 per share of Apellis common stock on The Nasdaq Global Select Market on September 11, 2019, and is subject to certain adjustments under the terms of the capped …Nov 29, 2023 ... As of November 29, 2023, 4:00 PM, CST, Apellis Pharmaceuticals Inc's stock price was $50.30. Apellis Pharmaceuticals Inc is up 6.66% from its ...The Dividend Yield as of February 2024 (TTM) for Apellis Pharmaceuticals, Inc. ( APLS) is 0%. According to Apellis Pharmaceuticals, Inc. ’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.The market expects Apellis Pharmaceuticals, Inc. (APLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023.Feb 16, 2024 · $ 68.80 0.02 0.03% After Hours Volume: 29.24K Advanced Charting Volume: 991.89K 65 Day Avg: 2.09M 47% vs Avg 67.10 Day Range 69.20 19.83 52 Week Range 94.75 Partner Center Your Watchlists Customize... Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Apellis Pharmaceuticals, Inc. (APLS) shares ended the last trading session 14.7% higher at $68.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Apellis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.... Apellis Pharmaceuticals's stock performance. The page ... The company also highlighted high patient compliance rates and increased use of the EMPAVELI Injector.In another report released on November 6, Bank of America Securities also maintained a Hold rating on the stock with a $52.00 price target. See the top stocks recommended by analysts >>Apellis Pharmaceuticals, Inc. (APLS) shares ended the last trading session 14.7% higher at $68.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...Feb 16, 2024 · $ 68.80 0.02 0.03% After Hours Volume: 29.24K Advanced Charting Volume: 991.89K 65 Day Avg: 2.09M 47% vs Avg 67.10 Day Range 69.20 19.83 52 Week Range 94.75 Partner Center Your Watchlists Customize... Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2021-11-17 - 2 views Apellis Announces Closing of Previously Announced Exchanges of Approximately $201.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock 2021-07-26 - 5 viewsThe high in the last 52 weeks of Apellis Pharmaceuticals stock was 94.75. According to the current price, Apellis Pharmaceuticals is 72.61% away from the 52 …The stock's price-to-GF-Value ratio stands at 0.45, with a GuruFocus Value of $144.67, indicating that Apellis Pharmaceuticals Inc is currently categorized as a Possible Value Trap, Think Twice ...Historical stock closing prices for Apellis Pharmaceuticals, Inc. (APLS). See each day's opening price, high, low, close, volume, and change %.Apellis Pharmaceuticals stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! APLS forecast for the upcoming days Date Price Min Price Max Price; 2024-02-26: Price: 68.818: Min: 66.932: Max: ...Investors are always looking for stocks that are poised to beat at earnings season and Apellis Pharmaceuticals, Inc. (APLS Quick Quote APLS - Free Report) …Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.Apellis Pharmaceuticals, Inc. (APLS) Stock Price, News, Quote & History - Yahoo Finance Industry News Canada markets close in 3 hours 54 minutes S&P/TSX …What this means: InvestorsObserver gives Apellis Pharmaceuticals Inc. (APLS) an overall rank of 41, which is below average. Apellis Pharmaceuticals Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 41 means that 59% of stocks appear more favorable to our system.Apellis Pharmaceuticals, Inc. Price and EPS Surprise. ... (Strong Buy) stocks here. Clearly, recent earnings estimate revisions suggest that good things are …Apellis Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on …India, known for its rich cultural heritage and diverse traditions, is also a powerhouse when it comes to export industries. The country has a strong presence in several sectors, r...Apellis Pharmaceuticals: Empaveli Approved With A Broad Label May 18, 2021 3:19 PM ET Apellis Pharmaceuticals, Inc. (APLS) Stock ALXN 2 Comments 2 Likes ONeil TraderWith an $85 price objective, which significantly exceeds the current trading price, the report reflects a bullish stance on Apellis Pharmaceuticals’s financial prospects and market positioning ...Upgrades. $34 → $64. -5.03%. Sep 15, 2023. Show More Ratings. A list of analyst ratings for Apellis Pharmaceuticals (APLS) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.Future criteria checks 5/6. Apellis Pharmaceuticals is forecast to grow earnings and revenue by 59.3% and 31.4% per annum respectively. EPS is expected to grow by 59.9% per annum. Return on equity is forecast to be 7.6% in 3 years.6 days ago · Summary of all time highs, changes and price drops for Apellis Pharmaceuticals; Historical stock prices; Current Share Price: US$68.78: 52 Week High: US$94.75 WALTHAM, Mass., April 23, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced post hoc analyses from the 24-month, Phase 3 OAKS and DERBY studies evaluating SYFOVRE™ (pegcetacoplan injection) for the treatment of geographic …APLS - Apellis Pharmaceuticals, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)Apellis Pharmaceuticals faces competition from other companies developing drugs for GA. Find out why APLS stock is a Hold. ... Apellis' stock price …About Apellis Pharmaceuticals Inc (APLS.OQ). Company Information. Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company ...Apellis Pharmaceuticals Inc. Follow. Share. $67.59. After Hours: $67.80. (0.31%) +0.21. Closed: Feb 22, 4:42:04 PM GMT-5 · USD · NASDAQ · Disclaimer. search Compare to.Feb 23, 202406:27 PST. Investors are always looking for stocks that are poised to beat at earnings season and Apellis Pharmaceuticals, Inc. APLS may be one …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...Jan 31, 2024 ... As of January 31, 2024, 4:00 PM, CST, Apellis Pharmaceuticals Inc's stock price was $63.29. Apellis Pharmaceuticals Inc is down 4.06% from its ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...Apellis Pharmaceuticals (NASDAQ:APLS) raised ~$150m via its initial public offering ("IPO") back in November 2017, issuing just over 10.7m share at a price of $14 per share. The company described ...Apellis Pharmaceuticals Price Performance. Shares of APLS opened at $68.47 on Friday. The firm has a market cap of $8.11 billion, a PE ratio of -13.04 and a beta of 0.93. The firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06.These 21 analysts have an average price target of $65.0 versus the current price of Apellis Pharmaceuticals at $51.075, implying upside. Below is a summary of how these 21 analysts rated Apellis ...Nov 29, 2023 ... As of November 29, 2023, 4:00 PM, CST, Apellis Pharmaceuticals Inc's stock price was $50.30. Apellis Pharmaceuticals Inc is up 6.66% from its ...Apellis Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on ….